INTRODUCTION AND PURPOSE
Early intervention (EI) is a system of coordinated developmental and therapeutic services as federally mandated by Part C of the Individuals with Disabilities Education Act (IDEA). Part C authorizes states, with the incentive of federal financial support, to provide EI services for infants and toddlers with, or who are at risk, for developmental delays (DDs) and developmental diagnoses (DXs). 1 Children qualify for EI on the basis of the presence of a DX (eg, autism) or a DD and up to 40% of EI-enrolled children receive physical or occupational therapy. 2 We know very little about use of EI service by infants and toddlers with either a qualifying diagnosis or with documented DD. One reason is the differences in EI eligibility state to state for children with DD. 3 By studying utilization in one state that includes children with a qualifying DX and DD, we can gain understanding on the similarities and differences in these 2 groups.
Previous studies [4] [5] [6] [7] [8] examining therapy access have been limited by parent-reported receipt of services or have focused on the delivery of any services. To date, there are limited population studies that evaluate patterns of therapy use for children with DX and DD. The existing literature about EI and therapy use for children with DX is equivocal. Previous studies suggest that children with DX, compared with those with DD, face more barriers to accessing therapy services and receive fewer services and have more unmet need for therapy. [4] [5] [6] Yet, among EI-eligible children, those with DX (vs DD) are more likely to access EI. children with DX are accessing EI more than their peers with DDs, but may not be receiving appropriate amounts of therapy. Multiple variables 9 influence the level, intensity, and accessibility of children for EI services. The severity of the child' s condition likely plays a role and may be a better indicator of therapy needs. Although severity of children' s conditions might be expected to positively influence receipt of therapy, the reality is more complicated. Previous research suggests that children whose condition (DD or DX) more profoundly affected their function were more likely than their peers with milder conditions to receive EI, 7 but also have greater unmet need for therapy services. [4] [5] [6] Thus, the role of the type and severity of a child' s developmental condition on therapy service use is unclear.
To address these gaps, we examined therapy access, service use, and spending among infants and toddlers with presumed EI eligibility (ie, with a DX or DD) enrolled in one state' s Medicaid program. We chose a single state to limit state variability in EI eligibility. In addition, use of Medicaid data allowed us to examine place of therapy service use because Medicaid reimburses for therapy delivered in home and clinic settings. We further examined a proxy for condition severity (ie, number of comorbid chronic conditions) to determine its role in receipt of services for type of developmental condition (DD vs DX). To our knowledge, no published studies have examined differences in physical therapy (PT)/occupational therapy (OT) service use by condition type and severity and place of service. Given the ongoing crises with EI funding in most states 10 and uncertainty of Medicaid expansion, understanding and improving the efficiency of therapy service delivery and spending for Medicaid-eligible infants and toddlers with DX and DD, and varying severity, is critical.
The purpose of this study was to examine differences by type of condition (ie, DX vs DD and associated with presumed EI eligibility) and varying developmental vulnerability on PT and OT service use and spending among a statewide sample of infants and toddlers, enrolled in Colorado Medicaid.
METHODS

Sample Selection
The data source was the Centers for Medicare & Medicaid Analytic Extract data files for Colorado for years 2006-2008. Children were presumed EI eligible if they had a DX or DD that corresponded to federal IDEA mandates 1 and Colorado policy 11 for EI eligibility. Our sample' s developmental conditions included DD, cerebral palsy, Down syndrome, neurological impairment, 12 autism, and any complex chronic condition (Supplemental Digital Content 1, available at: http://links.lww .com/PPT/A162).
The sample was restricted to children with DX or DD who were younger than 36 months with continuous Medicaid eligibility, defined as 9 of 12 calendar months. This definitional criterion aligns with similar eligibility determinations previously reported in the literature 13 and accounts for the lack of knowledge about therapy service use when children lose Medicaid eligibility or enrollment.
This study was approved by the Colorado Institutional Review Board.
Independent Variables
Condition Severity/Developmental Vulnerability. We included a measure of the number and type of the child' s comorbid complex chronic conditions. Using the algorithm developed by Fuedtner and colleagues, 14 we used International Classification of Diseases, Ninth Revision (ICD-9) codes to classify children as having a complex chromic condition in 1 of the following systems: neuromuscular, cardiovascular, musculoskeletal, respiratory, renal, gastrointestinal, hematologic/immune, metabolic, and congenital or other genetic. For these analyses, we chose to include the 4 most prevalent comorbid chronic condition (CCC) types and those that correspond to the diagnoses associated with automatic EI eligibility in Colorado. These CCC types (and their overall sample prevalence) were neuromuscular (9.1%), cardiovascular (22.0%), respiratory (8.7%), and genetic conditions (10.0%). We further categorized the number of comorbid CCCs as 0, 1, and 2 to reflect either the child' s primary developmental condition severity and/or developmental vulnerability.
Developmental Condition Type. Because children with one of the study DX often have a co-occurring DD, children were deemed to have a DX if they met the definitional criteria listed previously (regardless of co-occurring DD). Children were deemed to have a DD only if they only met the definitional criterion for DD (ie, no co-occurring DX).
MEASURES Outcome Measures
For each study child, therapy encounters (described later) were included if they occurred after the child' s initial diagnosis and before the child' s third birthday.
Utilization. Utilization of PT/OT was categorized as access, total claims, and dosage. Children were considered to have accessed PT/OT if they had at least 1 PT/OT claim during the study years. PT/OT claims were defined according to the following current procedural terminology (CPT) codes (accounting for >95% of sample CPT codes): Total number of claims was the sum of PT/OT claims for the study period, for children receiving PT/OT services.
Dosage. Annual PT/OT dosage was estimated by multiplying the annual total PT/OT claims for each child by the total number of service units. Service units are measured as estimates of the total number of 15-minute increments during which the child received PT/OT evaluation or treatment.
Spending. Total annual per study child Medicaid PT/OT spending (ie, total Medicaid per visit payments) was calculated as the sum of each Medicaid payment amount per PT/OT visit per study year, for study children receiving PT/OT.
Covariates
Child' s race and ethnicity were categorized as white, nonHispanic; black, non-Hispanic; Hispanic; other, non-Hispanic (including Asian, Pacific Islander, and multiracial families); and children of unknown race or ethnicity. We also included a covariate for child' s sex. Child' s age was grouped as less than 12 months, 12 to 23 months, and 24 to 35 months. To categorize children' s social disadvantage, we used a social disadvantage index. Details about this index have been reported previously. 15 In brief, the index includes Census data 16 collected at the ZIP code level, about 4 socioeconomic variables (percentage of female single head of household, percentage of non-Englishspeaking households, percentage of families living below the federal poverty level, and percentage of families participating in the supplemental nutrition assistance program). Social disadvantage index scores were categorized by tertile, with the lowest tertile indicating most social disadvantage. Rural/urban status was categorized according to Rural Urban Commuting Area (RUCA) codes. 17 RUCA codes are determined by the US Census definitions of population density, urbanization, and daily commuting information to characterize all of the nation' s Census tracts into rural and urban status. In addition, a ZIP code RUCA approximation was developed, which was linked to each study child' s resident ZIP code.
We categorized the primary place of PT/OT service as home or clinic on the basis of their relative frequency. For example, if 75% or more of the PT/OT visits occurred in the home setting, the primary place of PT/OT services was deemed to be the home. Type of service was derived from the previously described most common PT/OT CPT codes.
Analytic Approach
Descriptive statistics are presented for the whole sample, and separately, by number of CCCs and by condition type (ie, DX or DD).
Therapy Access. We first estimated the probability of receiving any PT/OT (ie, having at least 1 PT/OT claim), by number of CCCs, and calculated the difference between CCC groups. We then fit a logistic regression model to estimate the likelihood, or odds ratio, of any PT/OT for each CCC group, adjusting for condition type and other child and family characteristics. We then examined whether PT/OT access is different for children with CCCs if they have a DX versus a DD. To assist in the interpretation of this model, we calculated the predicted probability of receiving any PT/OT for each condition type and CCC group.
Total PT/OT Claims. We estimated the median annual per child total PT/OT claims and then calculated the differences by CCC groups. These models are interpreted as the additional total annual median PT/OT claims for children with 1 versus 0 and 2 versus 0 comorbid CCCs.
Total PT/OT Dosage. We estimated the median annual per child total PT/OT dosage and then calculated the differences by CCC groups. These models are interpreted as the additional annual median PT/OT total dosage associated with having 1 versus 0 and 2 versus 0 CCCs.
Total Annual Medicaid PT/OT Spending. To estimate the differences in annual median per child Medicaid PT/OT spending by CCC group, we fit 2 sets of multivariable quantile regression models. We used a quantile regression (also referred to as median regression) because the median is not as sensitive to outliers as the mean. The first model included CCC group, PT/OT dosage, in addition to other child and family characteristics. The second model further included primary place of PT/OT service (home vs clinic), and the 6 most commonly reported PT/OT procedures. For these models, the estimate for the CCC groups is interpreted as the additional annual median Medicaid spending associated with providing PT/OT for children with 1 versus 0 and 2 versus 0 CCCs.
We then examined whether PT/OT spending is different for children with CCCs if they have a DX versus a DD. To do this, we used a quantile regression model to estimate PT/OT spending for each group of children on the basis of condition type (DX and DD) and CCC group (0, 1, 2). To assist in the interpretation of this model, we present the PT/OT spending for each condition type and CCC group.
Data management and descriptive statistics were conducted using SAS v9.3 18 and the median quantile regression models were conducted in STATA13.
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RESULTS
There were 59 323 children with DX or DD between 2006 and 2008. Of those, 30 287 were younger than 36 months during the study years, and of those, 20 959 were continuously Medicaid eligible. Among the whole sample, 52.48% of children had no CCC, 36.18% had 1 CCC, and 11.35% had at least 2 CCCs. Nearly three-fourths (71.64%) of the sample had a DX, 29.09% were Hispanic, and 83.31% lived in an urban setting. Approximately 1 in 5 sample children (20.67%) were infants younger than 12 months (Table 1) .
PT/OT Access
Overall, 14.43% received PT/OT. Approximately 11% of children with no (11.55%) or 1 (11.0%) CCC received PT/OT, whereas 38.73% of children with at least 2 CCCs received PT/OT (Table 1) . Children with 1 CCC and those with at least 2 CCCs were more likely (based on an odds ratio) to receive PT/OT than children with no CCC (Table 2) . Compared with their peers with DX, sample children with DD were 12-fold more likely to receive any PT/OT (Table 2 ). Figure 1 graphs the adjusted probabilities of receiving PT/OT for each CCC group, by developmental condition. The highest probability of PT/OT use is for children with a DD and at least 2 CCCs (72.5%), and the lowest is for children with no CCC who have a DX (5.7%). Overall, number of CCCs is positively associated with receipt of PT/OT. In addition, there is a difference in this association, whereby for each CCC group, children with a DD are significantly more likely to receive PT/OT. 
PT/OT Claims and Dosage
Compared with children with no CCC, children with 2 CCCs had 13 more PT/OT claims and 556 more billable units (ie, 139 more hours) of PT/OT annually. Compared with children with no CCC, children with 1 CCC had 6 more PT/OT claims and 177 more billable units (ie, about 44.5 hours) annually (Table 3 ).
Spending
Annual per child PT/OT spending for children with at least 2 CCCs was about $172 higher than spending for children with no CCC, even adjusting for child and family characteristics and PT/OT dosage (Supplemental Digital Content 2, available at: http://links.lww.com/PPT/A163). When we further adjusted for place of service (home vs clinic) and type of service (eg, sensory integration), there was still a significant spending difference of about $26 between children with 2 versus no CCCs (Supplemental Digital Content 2 [http://links.lww.com/PPT/A163]).
Median annual per child PT/OT spending was $108 higher for children with DD compared with their peers with DX, even adjusting for child and family characteristics and PT/OT dosage (Supplemental Digital Content 2 [http://links.lww.com/ PPT/A163]). When primary place of PT/OT service and PT/OT procedure type are included in the model (Supplemental Digital Content 2 [http://links.lww.com/PPT/A163]), the spending differences between children with a DX versus a DD are no longer statistically significant. Figure 2 shows the adjusted annual per child PT/OT spending for each CCC group, by developmental condition. The highest PT/OT spending occurs among children with a DD and at least 2 CCCs ($341.58), and the lowest is for children with no CCC who have a DX ($117.11). Overall, number of CCCs is positively associated PT/OT spending. In addition, there is a difference in this association, whereby for each CCC group, children with a DD are more likely to receive PT/OT and these differences are statistically significant.
DISCUSSION
In this study we found that EI-eligible children with greater comorbid CCCs are more likely to receive PT/OT, and at greater doses, than children with no comorbid CCC. Moreover, EIeligible children with a DX receiving therapy services funded by Medicaid accessed PT/OT less often than their peers with a DD, and when they did access PT and OT, they received less intensive and less specialized services. Finally, when condition type and number of CCCs are examined together, we found that children with DD and at least 2 comorbid CCCs are most likely to receive PT/OT whereas children with a DX and no comorbid CCC are least likely to receive PT/OT. This finding is consistent with previous literature [4] [5] [6] suggesting therapy access barriers for children with disabilities. Yet, this is the first published article to demonstrate differences in PT/OT receipt, dosage, and spending by condition type and severity.
We found large differences in therapy dosage by condition type even accounting for number of CCCs. Our results suggest that children with DD typically received 80 minutes of PT/OT weekly, whereas children with disabilities typically received 15 minutes weekly. Previous research suggests that caregivers of children with disabilities experienced greater caregiver stress and related this to coordinating and managing multiple appointments. 20 Thus, it is plausible that the psychosocial burden of caring for a child with a disability negatively influences parents' capacity to engage with therapy services as fre- quently as parents of children with DDs. Moreover, it is also possible that the therapy treatment regimens for children with DX are more complex and involved, which precludes many families, particularly those with limited resources, from engaging fully, which has been previously reported. Another study finding is that annual Medicaid PT/OT per child spending is highest for children with more comorbid CCCs. Yet, disparities exist by condition type such that, regardless of CCC group, PT/OT spending is higher for children with DD than with DX. We have limited extant literature to which to compare our results. However, our results suggesting a median annual spending of $146 per child with a disability are consistent with spending estimates ($129 annually) for a similar sample from the National Early Intervention Longitudinal Study (NEILS). Our findings are similar to estimates of PT/OT spending for Medicaid EI children in NEILS, given assumptions related to therapy use (37% of NEILS children), Medicaid spending (18% of overall Part C spending), and PT/OT reimbursement caps (eg, 48 units in Colorado) are applied. Yet, although our results indicate annual per child spending of $309 for children with DD, spending for a similar sample of children with DD (from NEILS) is $102 per child annually.
Moreover, when we account for the location of PT/OT service and PT/OT procedures, we no longer observe differences by condition type in Medicaid PT/OT spending. Thus, our results indicate that children with DD are more likely to receive costly specialized PT/OT (ie, sensory integration therapy, assistive device training, or neuromuscular reeducation) and more clinic-based PT/OT than children with DX. Our findings are consistent with previous literature and suggest that, compared with children with DD, children with DX and those with complex conditions are more likely to face barriers to receiving appropriate therapy services.
2,4-6 Indeed, previous research suggests shortages of pediatric PTs and OTs with expertise to treat high-risk infants, 21 and high-risk infants are substantially more likely to receive a referral for private physical or occupational therapy services rather than EI. 22 Other research suggests that children with severe conditions are more likely than their counterparts with less severe conditions to report lack of availability and affordability of PT/OT services as therapy access barriers. 6 Taken together, our results suggest that the current EI system may be providing inadequate services to families of children with DX. Thus, it is critical that PTs and OTs are aware of these therapy access disparities and develop family-centered outreach and intervention strategies whether they are providing services in a clinic setting or through a home-based EI program.
We acknowledge the study limitations. The data were from 1 state and represent only 3 years. It is possible that, after 2008, trends in PT and OT utilization and spending differ. When we were moving to a full implementation of the Affordable Care Act (ACA), it appeared that many more children in Colorado (and nationally) would become Medicaid eligible and a modest proportion of these children would also require PT/OT services. Although there is currently greater uncertainty relative to the continuation of the ACA, some form of public support is likely to continue for these vulnerable children. Thus, understanding therapy utilization for this high-risk group has important implications for PT/OT service delivery. Second, we recognize that we cannot confirm eligibility or participation in EI therapy services. In this study we attribute the receipt of PT/OT home visits to EI, particularly given that Part C is the most common source of therapy services for infants and toddlers with DD and DX, yet we cannot confirm this. We acknowledge that we were limited to a child' s diagnosis to determine need for PT/OT and had no measure of child' s function. We were restricted in our analyses to quantity of PT/OT services because we have no measure of quality.
Our study has several strengths. We created a sample of children with DX and DD who would presumably need PT/OT services. Our study findings have programmatic and policy implications related to the ACA or subsequent public funding for health care. Understanding Medicaid therapy spending for EIeligible children is critical to understand systems coordination, quality, and efficiency. Finally, use of administrative Medicaid billing data in the current study allowed us to examine PT/OT dosage and spending. Furthermore, PT/OT providers of EI services should be acutely aware of the many contributing factors associated with a child receiving services for a DD or DX and work with the family to eliminate as many of those barriers as possible. The goal should always be focused on the child' s development, such that therapy services are of the highest quality and delivered with an intensity that maximizes each available interaction.
